Kathleen E. Meyer
Impact in
- Genetics top 10%
- Virus-based gene therapy research
Papers in
- Genetics 11
- Virus-based gene therapy research 11
- Neurogenetic and Muscular Disorders Research 2
-
- Lysosomal Storage Disorders Research 6
- Co-authors
- Michael C. Holmes (9 shared papers)Susan S. Martin (5 shared papers)Thomas Wechsler (8 shared papers)Scott Sproul (7 shared papers)Michelle Rohde (4 shared papers)R. Scott McIvor (3 shared papers)Li Ou (4 shared papers)Robert Radeke (3 shared papers)
- Journals
- Molecular Therapy (5 papers)Molecular Therapy — Methods & Clinical Development (5 papers)Molecular Genetics and Metabolism (3 papers)Blood (2 papers)Pain Medicine (2 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Kathleen E. Meyer
20 papers receiving 511 citations
Peers
Comparison fields: 5 of 50
- Business and International Management 21
- Genetics 226
- Physiology 148
- Virology 26
- Molecular Biology 332
Countries citing papers authored by Kathleen E. Meyer
This map shows the geographic impact of Kathleen E. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen E. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen E. Meyer more than expected).
Fields of papers citing papers by Kathleen E. Meyer
This network shows the impact of papers produced by Kathleen E. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen E. Meyer. The network helps show where Kathleen E. Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathleen E. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 99 | |
| 2 | 2016 | 92 | |
| 3 | 2018 | 67 | |
| 4 | 2022 | 61 | |
| 5 | 2020 | 47 | |
| 6 | 2020 | 34 | |
| 7 | 1985 | 24 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2024 | 11 | |
| 13 | 2023 | 9 | |
| 14 | 2017 | 9 | |
| 15 | 2015 | 4 | |
| 16 | 2024 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2001 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 1 |
About Kathleen E. Meyer
Kathleen E. Meyer is a scholar working on Genetics, Physiology, Molecular Biology, Oncology and Genetics, having authored 21 papers that have together received 534 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (11 papers), Virus-based gene therapy research (11 papers), Lysosomal Storage Disorders Research (6 papers), CAR-T cell therapy research (5 papers), Trypanosoma species research and implications (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). The work is most often cited by research in Business and International Management (21 citations), Genetics (226 citations), Physiology (148 citations), Virology (26 citations) and Molecular Biology (332 citations). Kathleen E. Meyer has collaborated with scholars based in United States and Canada. Frequent co-authors include Michael C. Holmes, Susan S. Martin, Thomas Wechsler, Scott Sproul, Michelle Rohde, R. Scott McIvor, Li Ou, Robert Radeke, Kelly M. Podetz-Pedersen and Kanut Laoharawee. Their work appears in journals such as Molecular Therapy, Molecular Therapy — Methods & Clinical Development, Molecular Genetics and Metabolism, Blood and Pain Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.